 |
Temozolomide is an oral chemotherapy drug that effectively targets brain tumors, particularly glioblastoma multiforme (GBM) and anaplastic astrocytoma. It works by damaging the DNA of cancer cells, preventing them from replicating and growing. Unlike many other drugs, Temozolomide can cross the blood-brain barrier, a challenge that often limits the effectiveness of cancer treatments for brain tumors. This unique property allows it to directly target malignant cells in the brain, providing a crucial treatment option. Temozolomide is typically used in combination with radiation therapy to enhance its effectiveness and improve patient outcomes. Though effective, the drug may cause side effects like nausea, fatigue, and reduced white blood cell counts. Regular monitoring during treatment is essential. Leading manufacturer of Temozolomide ensure high-quality production, adhering to stringent standards to provide a reliable and effective option for patients battling aggressive brain cancers.
|
